Currently also: Chief Informatics and Technology Officer (CITO) at Pangea Botanica, London/UK and Berlin/Germany
Previous positions:
Director Digital Chemistry at NUVISAN Berlin
Associate Director Computational ADME and Safety (Clinical Pharmacology & Safety Sciences/Data Science and Artificial Intelligence - CPSS/DSAI) at AstraZeneca Cambridge
Co-founder of Healx Ltd.
Co-founder of PharmEnable Ltd.
- Committed to developing new life science data analysis methods (AI/ML/data science) and their application, primarily related to chemical biology, drug discovery and in silico toxicology
- Expertise comprises data ranging from chemical structure and gene expression data to phenotypic readouts and preclinical information, applied to both efficacy- and safety/tox-related questions
- Collaborating with academic research groups, as well as pharmaceutical, chemical, and consumer goods companies (Eli Lilly, AstraZeneca, GSK, BASF, Johnson&Johnson/Janssen, Unilever, ...)
- Co-founder/founding CTO and current SAB member of Healx Ltd. (data-driven drug repurposing for rare diseases, and beyond); co-founder of PharmEnable Ltd.; SAB member of Lhasa Ltd. (toxicology and metabolism prediction) and Cresset Ltd.
- Coordinator of the Computational & In Silico Toxicology Specialty Section of the British Toxicology Society (BTS)
- Steering Committee Member of the Cambridge Alliance on Medicines Safety (CAMS)
- Currently leading a group of ca. 15 PhD students, postdocs, project students and visitors at the Centre for Molecular Informatics at the University of Cambridge, https://www-cmi.ch.cam.ac.uk/centre-molecular-informatics
Publications
Characterizing bitterness: Identification of key structural features and development of a classification model
J Chem Inf Model
(2006)
46
569
(doi: 10.1021/ci0504418)
Diversity Oriented Synthesis: A Challenge for Synthetic Chemists
Ernst Schering Foundation Symposium Proceedings
(2006)
58
47
(doi: 10.1007/978-3-540-37635-4_4)
Molecular similarity searching using COSMO screening charges (COSMO/3PP)
Lecture Notes in Computer Science
(2005)
3695
175
(doi: 10.1007/11560500_16)
Screening for dihydrofolate reductase inhibitors using MOLPRINT 2D, a fast fragment-based method employing the naïve Bayesian classifier: Limitations of the descriptor and the importance of balanced chemistry in training and test sets
Journal of biomolecular screening
(2005)
10
658
(doi: 10.1177/1087057105281048)
Discussion of measures of enrichment in virtual screening: Comparing the information content of descriptors with increasing levels of sophistication
J CHEM INF MODEL
(2005)
45
1369
(doi: 10.1021/ci0500177)
Assessment of structural diversity in combinatorial synthesis
Current Opinion in Chemical Biology
(2005)
9
304
(doi: 10.1016/j.cbpa.2005.03.004)
General melting point prediction based on a diverse compound data set and artificial neural networks
J Chem Inf Model
(2005)
45
581
(doi: 10.1021/ci0500132)
Encoding and decoding graphical chemical structures as two-dimensional (PDF417) barcodes.
Journal of chemical information and modeling
(2005)
45
572
(doi: 10.1021/ci049758i)
Molecular surface point environments for virtual screening and the elucidation of binding patterns (MOLPRINT 3D).
J Med Chem
(2004)
47
6569
(doi: 10.1021/jm049611i)
Molecular similarity: A key technique in molecular informatics
Organic & biomolecular chemistry
(2004)
2
3204
(doi: 10.1039/b409813g)
- ‹ previous
- Page 40
